Transposon-based gene delivery vectors for gene therapy
The first gene therapy clinical trials were initiated more than two decades ago thanks to the previous development of viral vectors that allow high efficiency gene transfer into mammalian cells. Since then the application of viral gene transfer has been a successful treatment option for a variety of...
Elmentve itt :
Szerzők: |
Nagy Andrea Imre Gergely Mátés Lajos |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2015
|
Sorozat: | Acta biologica Szegediensis
59 |
Kulcsszavak: | Génsebészet, Genetika klinkai |
Online Access: | http://acta.bibl.u-szeged.hu/35901 |
Hasonló tételek
-
Prolonged activity of the transposase helper may raise safety concerns during DNA transposon-based gene therapy
Szerző: Imre Gergely, et al.
Megjelent: (2023) -
Gene therapy, artificial chromosome
Szerző: Nagy Nikoletta -
Artificial metallonucleases - molecular tools for gene therapy of cancer
Szerző: Abd Elhameed Heba Alaa Eldeen Hosiny
Megjelent: (2020) -
Development and optimization of self-assembling modified beta-cyclodextrin-based nanocarriers for gene delivery [abstract] /
Szerző: Chiarugi Ilaria, et al.
Megjelent: (2025) -
Drosophila small ovary gene is required for transposon silencing and heterochromatin organization, and ensures germline stem cell maintenance and differentiation
Szerző: Jankovics Ferenc, et al.
Megjelent: (2018)